Top Markets
#1 TENDIES TENDIES +60.89%
#2 Threshold Network Threshold Network +54.06%
#3 Cash Cat Cash Cat +21.98%
#4 OSK OSK +16.53%
#5 Kinetiq Kinetiq +16.42%
#6 Mubarak Mubarak +13.34%
#7 Maple Finance Maple Finance +13.30%
#8 Ape and Pepe Ape and Pepe +12.62%
#9 Magma Finance Magma Finance +12.08%
#10 Kite Kite +11.50%
Coin of the day
TENDIES TENDIES
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Invivyd, Inc. Invivyd, Inc.

Invivyd, Inc.

IVVD
Clasificación en acciones #17262
Adagio Therapeutics, Inc., a biopharmaceutical firm in its clinical development... Adagio Therapeutics, Inc., a biopharmaceutical firm in its clinical development phase, operates within the United States, specializing in the discovery, progression, and marketing of antibody-derived solutions for infectious diseases. The company's leading drug candidate, ADG20 (adintrevimab), is a neutralizing antibody currently undergoing Phase 3 clinical investigation for both the management and prevention of coronavirus disease. Adagio Therapeutics maintains collaborative agreements with Adimab, LLC to facilitate the identification and enhancement of its exclusive antibodies. Furthermore, it partners with the Scripps Research Institute to conduct studies aimed at uncovering potential vaccine solutions for the prophylaxis, detection, or therapy of influenza or beta coronaviruses. Incorporated in 2020, the company's base of operations is in Waltham, Massachusetts.
Precio por acción
$0.873
Capitalización bursátil
$257.19M
Cambio (1 día)
-0.78%
Cambio (1 año)
-15.24%
País
US
Comercio Invivyd, Inc. (IVVD)

Categoría

Healthcare
Ingresos de Invivyd, Inc. (IVVD)
Ingresos en Sep 2026 TTM: 0
Según los últimos informes financieros de Invivyd, Inc., los ingresos actuales de la empresa (TTM) son 0. En 2026, la empresa obtuvo unos ingresos de 0 igual a los ingresos del año 2026, que fueron de 0. Los ingresos representan la cantidad total que una empresa genera por la venta de bienes o servicios. A diferencia de las ganancias, no se restan los gastos.
Historial de ingresos de Invivyd, Inc. desde 2026 hasta 2026
Ingresos al final de cada año
Año Ingresos Cambiar
Not enough data for the provided dates.
Ingresos de empresas similares o competidoras
Empresa Ingresos Diferencia de ingresos País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH